Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): A randomised, placebo-controlled trial

Journal of the International Society of Sports Nutrition

Volumn 11, Issue 1, 2014, Pages

  Drobnic, Franchek ^a   Riera, Joan ^a   Appendino, Giovanni ^b   Togni, Stefano ^c   Franceschi, Federico ^c   Valle, Xavier ^d   Pons, Antoni ^e   Tur, Josep ^e  

^a Olympic Training Center CAR   (Spain)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c INDENA S P A   (Italy)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Curcumin; DOMS; Meriva ; Sport nutrition

Indexed keywords

EID: 84902300218     PISSN: None     EISSN: 15502783     Source Type: Journal    
DOI: 10.1186/1550-2783-11-31     Document Type: Article

References (56)

1. Armstrong RB. Initial events in exercise-induced muscular injury. Med Sci Sports Exerc 1990, 22:429-435.
2. Francis KT, Hoobler T. Effects of aspirin on delayed muscle soreness. J sports Med Physical Fitness 1987, 27:333-337.
3. Beck TW, Housh TJ, Johnson GO, Schmidt RJ, Housh DJ, Coburn JW, Malek MH, Mielke M. Effects of a protease supplement on eccentric exercise-induced markers of delayed-onset muscle soreness and muscle damage. J Strength Cond Res/ National Strength & Conditioning Association 2007, 21:661-667.
4. Cockburn E, Hayes PR, French DN, Stevenson E. St Clair Gibson A: Acute milk-based protein-CHO supplementation attenuates exercise-induced muscle damage. Applied physiology, nutrition, and metabolism = Physiol Appl Nutr Metab 2008, 33:775-783.
5. Dudley GA. Muscle pain prophylaxis. Inflammopharmacology 1999, 7:249-253.
6. Gulick DT, Kimura IF, Sitler M, Paolone A, Kelly JD. Various treatment techniques on signs and symptoms of delayed onset muscle soreness. J Athl Train 1996, 31:145-152.
7. Zainuddin Z, Newton M, Sacco P, Nosaka K. Effects of massage on delayed-onset muscle soreness, swelling, and recovery of muscle function. J Athl Train 2005, 40:174-180.
8. Proske U, Morgan DL. Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 2001, 537:333-345.
9. Aoi W, Naito Y, Takanami Y, Kawai Y, Sakuma K, Ichikawa H, Yoshida N, Yoshikawa T. Oxidative stress and delayed-onset muscle damage after exercise. Free Radic Biol Med 2004, 37:480-487.
10. Pizza FX, Peterson JM, Baas JH, Koh TJ. Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice. J Physiol 2005, 562:899-913.
11. Tauler P, Aguilo A, Cases N, Sureda A, Gimenez F, Villa G, Cordova A, Biescas AP. Acute phase immune response to exercise coexists with decreased neutrophil antioxidant enzyme defences. Free Radic Res 2002, 36:1101-1107.
12. Ferrer MD, Tauler P, Sureda A, Pujol P, Drobnic F, Tur JA, Pons A. A soccer match's ability to enhance lymphocyte capability to produce ROS and induce oxidative damage. Int J Sport Nutr Exerc Metab 2009, 19:243-258.
13. Julius D. TRP channels and pain. Annu Rev Cell Dev Biol 2013, 29:355-384.
14. Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 2007, 130:769-774.
15. Singh S. From exotic spice to modern drug?. Cell 2007, 130:765-768.
16. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008, 65:1631-1652.
17. Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 2011, 74:664-669.
18. Steigerwalt R, Nebbioso M, Appendino G, Belcaro G, Ciammaichella G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone MR, Ippolito E, Errichi BM, Ledda A, Hosoi M, Corsi M. Meriva(R), a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med 2012, 54:11-16.
19. Mazzolani F. Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy. Clin Ophthalmol 2012, 6:801-806.
20. Ledda A, Belcaro G, Dugall M, Luzzi R, Scoccianti M, Togni S, Appendino G, Ciammaichella G. Meriva(R), a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. Panminerva Med 2012, 54:17-22.
21. Belcaro G, Hosoi M, Pellegrini L, Appendino G, Ippolito E, Ricci A, Ledda A, Dugall M, Cesarone MR, Maione C, Ciammaichella G, Genovesi D, Togni S. A Controlled Study of a Lecithinized Delivery System of Curcumin (Meriva(R)) to Alleviate the Adverse Effects of Cancer Treatment. Phytother Res 2014, 28(3):444-450.
22. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G. Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alternative medicine review : a journal of clinical therapeutic 2010, 15:337-344.
23. Di Pierro F, Rapacioli G, Di Maio EA, Appendino G, Franceschi F, Togni S. Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva((R))), nimesulide, and acetaminophen. J Pain Res 2013, 6:201-205.
24. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 1999, 163:3474-3483.
25. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995, 270:24995-25000.
26. Alamdari N, O'Neal P, Hasselgren PO. Curcumin and muscle wasting: a new role for an old drug?. Nutrition 2009, 25:125-129.
27. Thaloor D, Miller KJ, Gephart J, Mitchell PO, Pavlath GK. Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol 1999, 277:C320-C329.
28. Dunsmore KE, Chen PG, Wong HR. Curcumin, a medicinal herbal compound capable of inducing the heat shock response. Crit Care Med 2001, 29:2199-2204.
29. Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 2003, 24:1515-1524.
30. Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. BioFactors 2013, 39:27-36.
31. Davis JM, Murphy EA, Carmichael MD, Zielinski MR, Groschwitz CM, Brown AS, Gangemi JD, Ghaffar A, Mayer EP. Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. American journal of physiology Regulatory, integrative and comparative physiology 2007, 292:R2168-R2173.
32. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol Respir Environ Exerc Physiol 1983, 55:1558-1564.
33. Wasserman K, Beaver WL, Whipp BJ. Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation 1990, 81:II14-II30.
34. Nurenberg P, Giddings CJ, Stray-Gundersen J, Fleckenstein JL, Gonyea WJ, Peshock RM. MR imaging-guided muscle biopsy for correlation of increased signal intensity with ultrastructural change and delayed-onset muscle soreness after exercise. Radiology 1992, 184:865-869.
35. Malm C, Sjodin TL, Sjoberg B, Lenkei R, Renstrom P, Lundberg IE, Ekblom B. Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J Physiol 2004, 556:983-1000.
36. Cleary MA, Kimura IF, Sitler MR, Kendrick ZV. Temporal Pattern of the Repeated Bout Effect of Eccentric Exercise on Delayed-Onset Muscle Soreness. J Athl Train 2002, 37:32-36.
37. Smith LL, McKune AJ, Semple SJ, Sibanda E, Steel H, Anderson R. Changes in serum cytokines after repeated bouts of downhill running. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2007, 32:233-240.
38. McNeil PL, Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 1992, 140:1097-1109.
39. Nosaka K, Clarkson PM. Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Med Sci Sports Exerc 1996, 28:953-961.
40. Orozco-Levi M, Gea J, Lloreta JL, Felez M, Minguella J, Serrano S, Broquetas JM. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999, 13:371-378.
41. Artells R, Navarro A, Diaz T, Monzo M. Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestine. Anat Rec 2011, 294:462-471.
42. Jiang TX, Reid WD, Belcastro A, Road JD. Load dependence of secondary diaphragm inflammation and injury after acute inspiratory loading. Am J Respir Crit Care Med 1998, 157:230-236.
43. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997, 139:375-385.
44. Gosker HR, Kubat B, Schaart G, van der Vusse GJ, Wouters EF, Schols AM. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 2003, 22:280-285.
45. Gomez-Cabrera MC, Domenech E, Romagnoli M, Arduini A, Borras C, Pallardo FV, Sastre J, Vina J. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr 2008, 87:142-149.
46. Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, Bluher M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 2009, 106:8665-8670.
47. Handler N, Jaeger W, Puschacher H, Leisser K, Erker T. Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors. Chem Pharm Bull 2007, 55:64-71.
48. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, Yang CS. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 2004, 25:1671-1679.
49. Schoenfeld BJ. Does exercise-induced muscle damage play a role in skeletal muscle hypertrophy?. J Strength Cond Res/National Strength & Conditioning Association 2012, 26:1441-1453.
50. Koeberle A, Northoff H, Werz O. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Mol Cancer Ther 2009, 8:2348-2355.
51. Meneghel AJ, Verlengia R, Crisp AH, Aoki MS, Nosaka K, Da Mota GR, Lopes CR. Muscle damage of resistance-trained men after two bouts of eccentric bench press exercise. J Strength Cond Res/National Strength & Conditioning Association 2014, In press.
52. Leamy AW, Shukla P, McAlexander MA, Carr MJ, Ghatta S. Curcumin ((E, E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. Neurosci Lett 2011, 503:157-162.
53. Yeon KY, Kim SA, Kim YH, Lee MK, Ahn DK, Kim HJ, Kim JS, Jung SJ, Oh SB. Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. J Dent Res 2010, 89:170-174.
54. Das L, Vinayak M. Long term effect of curcumin down regulates expression of TNF-alpha and IL-6 via modulation of ETS and NF-kappaB transcription factor in liver of lymphoma bearing mice. Leukemia & lymphoma 2014, In press.
55. Fu Y, Gao R, Cao Y, Guo M, Wei Z, Zhou E, Li Y, Yao M, Yang Z, Zhang N. Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-kappaB signaling pathway in lipopolysaccharide-induced mastitis in mice. Int Immunopharmacol 2014, 20(1):54-58.
56. Belcaro G, Cesarone MR, Dugall M. Product evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med 2010, 52:55-62.